Abstract | OBJECTIVE:
Estrogen is a well-known oncogenic driver in endometrial (ECs) and breast cancers (BCs). Programmed cell death protein 1 (PD-1) and its ligands PD-1 Ligand 1 (PD-L1) and PD-L2 have been shown to mediate immune evasion of the tumor cells. The purpose of the present study was to assess the effects of estrogen on PD-L1 and PD-L2 expression in EC and BC cell lines. METHODS: 17β-Estradiol (E2)-induced expression of PD-L1 and PD-L2 and possible signaling pathway were investigated in EC and BC cells. Coculture of T cells and cancer cells with E2 stimulation was performed to assess the functions of T cells. RESULTS: We found that E2 increased expression of PD-L1, but not PD-L2, protein via activation of phosphoinositide 3-kinase (PI3K)/Akt pathway in Ishikawa and Michigan Cancer Foundation-7 (MCF-7) cells. Phosphoinositide 3-kinase and Akt inhibitors could block E2's effects. 17β-Estradiol did not increase PD-L1 mRNA transcription, but stabilized PD-L1 mRNA. 17β-Estradiol's effects were only observed in estrogen receptor α (ERα)-positive Ishikawa and MCF-7 cells, but not in ERα-negative MDA-MB-231 cells. Coculture of Ishikawa or MCF-7 cells with T cells inhibited expression of interferon-γ and interleukin-2 and increased BCL-2-interacting mediator of cell death expression in the presence of E2. CONCLUSIONS: This study provides the first evidence that estrogen upregulates PD-L1 protein expression in ERα-positive EC and BC cells to suppress immune functions of T cells in the tumor microenvironment, demonstrating a new mechanism of how estrogen drives cancer progression.
|
Authors | Lingyun Yang, Feng Huang, Jiandong Mei, Xun Wang, Qiuyang Zhang, Hongjing Wang, Mingrong Xi, Zongbing You |
Journal | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
(Int J Gynecol Cancer)
Vol. 27
Issue 2
Pg. 196-205
(02 2017)
ISSN: 1525-1438 [Electronic] England |
PMID | 27870715
(Publication Type: Journal Article)
|
Chemical References |
- B7-H1 Antigen
- CD274 protein, human
- ESR1 protein, human
- Estrogen Receptor alpha
- RNA, Messenger
- Estradiol
- Proto-Oncogene Proteins c-akt
|
Topics |
- B7-H1 Antigen
(biosynthesis, genetics)
- Breast Neoplasms
(enzymology, genetics, immunology, metabolism)
- Cell Line, Tumor
- Endometrial Neoplasms
(enzymology, genetics, immunology, metabolism)
- Estradiol
(pharmacology)
- Estrogen Receptor alpha
(biosynthesis)
- Female
- Humans
- Jurkat Cells
- MCF-7 Cells
- Phosphatidylinositol 3-Kinases
(metabolism)
- Proto-Oncogene Proteins c-akt
(metabolism)
- RNA Processing, Post-Transcriptional
(drug effects)
- RNA, Messenger
(genetics, metabolism)
- Signal Transduction
(drug effects)
- T-Lymphocytes
(drug effects, immunology)
|